Dear DF/HCC Colleagues,
A funding opportunity previously limited to DFCI investigators (the Dana-Farber/Novartis Drug Discovery & Translational Research Program, DDTRP) will soon open to all independent investigators at DF/HCC member institutions. Applicants need not be DF/HCC members, but they must work at one of our seven consortium institutions.
DDTRP terms are still being reviewed by individual institutions. If those terms are acceptable to all parties, independent investigators at all DF/HCC member institutions will be eligible to apply for DDTRP awards.
DF/HCC does not administer this program, but I wanted to pass along the message so you could begin to prepare for the DDTRP's non-confidential grant summary submission deadline of 2/1/21.
I have included a copy of the DDTRP RFA here, and direct you to the DDTRP page here for additional details on eligibility, key dates, and to sign up for the January 13th 1-2pm virtual information session.
If you should have any questions about the DDTRP program, please contact the program administrator, Sylvia Lin at Sylvia_Lin@dfci.harvard.edu.
I wish you the best of luck should you choose to submit a grant summary application!
